Beauty Farm Medical and Health Industry Inc. filed a resubmitted monthly return for the period ended 30 June 2026, detailing an active share-repurchase programme that trimmed its free-floating equity base while keeping overall issued capital unchanged.

Key Highlights • Share repurchases: 886,500 ordinary shares were bought back across 20 on-market transactions between 1 and 30 June 2026 at prices ranging from HK$15.94 to HK$18.41 per share. • Cash outlay: Total consideration reached approximately HK$15.41 million, implying an average repurchase price of about HK$17.38 per share. • Impact on share base: Issued shares outstanding (excluding treasury shares) fell 0.36% month-on-month to 248.38 million, while treasury share holdings rose to 3.21 million. Total issued shares remained steady at 251.59 million. • Capital structure: Authorised share capital stayed at 10.00 billion ordinary shares with a par value of USD0.000005 each, equivalent to USD50,000. • Compliance status: The company confirmed adherence to the Main Board Listing Rule 13.32D(1), maintaining a public float above the 25% threshold. • No dilution instruments: The period saw no movements in share options, warrants, convertibles, or other equity-linked instruments.

The filing, dated 8 July 2026, was signed by Director Li Yang and affirms full compliance with all relevant listing and regulatory requirements.